Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 07/05/2024

Debbie Rigby rounds up the latest in research news Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Results from the STEP-HFpEF DM Trial show that semaglutide led to larger reductions in heart failure–related symptoms and physical limitations and greater weight loss than placebo at 1 year. Patients had heart failure with preserved

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Research Roundup

Previous Nurse fined following botox bust

Next No more aged care delays

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Nurse fined following botox bust

Next No more aged care delays

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.